(Q34510340)

2 August 2017

1 reference

title

Maturity testing with preterm premature rupture of the membranes (English)

1 reference

preterm premature rupture of the membranes

2 August 2017

main subject

0 references

author name string

Spinnato JA 2nd

series ordinal

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

published in

Clinics in Perinatology

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

819-36, vii

1 reference

Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

A retrospective study on the effects of steroid administration and prolongation of the latent phase in patients with preterm premature rupture of the membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Amniostat-FLM: an initial clinical trial with both vaginal pool and amniocentesis samples

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Racial differences in the predictive value of the TDx fetal lung maturity assay

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Lamellar body number density and the prediction of respiratory distress

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Antenatal steroids and intraventricular hemorrhage after premature rupture of membranes at 24-28 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Effectiveness of antenatal steroids in obstetric subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Amniotic fluid phospholipids after maternal administration of dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Morbidity in the preterm infant with mature lung indices

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Immature lecithin/sphingomyelin ratios and neonatal respiratory course

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Clinical and economic considerations associated with testing for fetal lung maturity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Role of the TDx FLM assay in fetal lung maturity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Testing for fetal pulmonary maturity: ROC analysis involving covariates, verification bias, and combination testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Use of Amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Racial differences in predictive value of the lecithin/sphingomyelin ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Comparison of phospholipids in vaginal and amniocentesis specimens of patients with premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Glucocorticoid effects on rabbit fetal lung maturation in vivo: an ultrastructural morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Management of preterm premature rupture of membranes: Assessing amniotic fluid in the vagina for phosphatidylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Evaluation of the new amniostat-FLM test for the detection of phosphatidylglycerol in contaminated fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

The effects of antenatal steroid use in premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Amniostat FLM: a new technique for detection of phosphatidylglycerol in amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

Neonatal morbidity after preterm delivery in the presence of documented lung maturity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2803%2900080-0

7 January 2021

10.1016/S0095-5108(03)00080-0

Identifiers

DOI

1 reference

2 August 2017

1 reference